Michael Yourshaw1, R Sergio Solorzano-Vargas, Lindsay A Pickett, Iris Lindberg, Jiafang Wang, Galen Cortina, Anna Pawlikowska-Haddal, Howard Baron, Robert S Venick, Stanley F Nelson, Martín G Martín. 1. *Department of Human Genetics, David Geffen School of Medicine †Department of Pediatrics, Division of Gastroenterology and Nutrition, Mattel Children's Hospital and David Geffen School of Medicine, University of California, Los Angeles ‡Department of Anatomy and Neurobiology, University of Maryland-Baltimore County, Baltimore, MD ¶Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California, Los Angeles #Department of Pediatrics, Division of Endocrinology, Mattel Children's Hospital and David Geffen School of Medicine, University of California, Los Angeles **Department of Pediatrics, University of Nevada School of Medicine, Las Vegas ‡‡Department of Human Genetics, David Geffen School of Medicine, University of California, Los Angeles.
Abstract
OBJECTIVES: Congenital diarrhea disorders are a group of genetically diverse and typically autosomal recessive disorders that have yet to be well characterized phenotypically or molecularly. Diagnostic assessments are generally limited to nutritional challenges and histologic evaluation, and many subjects eventually require a prolonged course of intravenous nutrition. Here we describe next-generation sequencing techniques to investigate a child with perplexing congenital malabsorptive diarrhea and other presumably unrelated clinical problems; this method provides an alternative approach to molecular diagnosis. METHODS: We screened the diploid genome of an affected individual, using exome sequencing, for uncommon variants that have observed protein-coding consequences. We assessed the functional activity of the mutant protein, as well as its lack of expression using immunohistochemistry. RESULTS: Among several rare variants detected was a homozygous nonsense mutation in the catalytic domain of the proprotein convertase subtilisin/kexin type 1 gene. The mutation abolishes prohormone convertase 1/3 endoprotease activity as well as expression in the intestine. These primary genetic findings prompted a careful endocrine reevaluation of the child at 4.5 years of age, and multiple significant problems were subsequently identified consistent with the known phenotypic consequences of proprotein convertase subtilisin/kexin type 1 (PCSK1) gene mutations. Based on the molecular diagnosis, alternate medical and dietary management was implemented for diabetes insipidus, polyphagia, and micropenis. CONCLUSIONS: Whole-exome sequencing provides a powerful diagnostic tool to clinicians managing rare genetic disorders with multiple perplexing clinical manifestations.
OBJECTIVES:Congenital diarrhea disorders are a group of genetically diverse and typically autosomal recessive disorders that have yet to be well characterized phenotypically or molecularly. Diagnostic assessments are generally limited to nutritional challenges and histologic evaluation, and many subjects eventually require a prolonged course of intravenous nutrition. Here we describe next-generation sequencing techniques to investigate a child with perplexing congenital malabsorptive diarrhea and other presumably unrelated clinical problems; this method provides an alternative approach to molecular diagnosis. METHODS: We screened the diploid genome of an affected individual, using exome sequencing, for uncommon variants that have observed protein-coding consequences. We assessed the functional activity of the mutant protein, as well as its lack of expression using immunohistochemistry. RESULTS: Among several rare variants detected was a homozygous nonsense mutation in the catalytic domain of the proprotein convertase subtilisin/kexin type 1 gene. The mutation abolishes prohormone convertase 1/3 endoprotease activity as well as expression in the intestine. These primary genetic findings prompted a careful endocrine reevaluation of the child at 4.5 years of age, and multiple significant problems were subsequently identified consistent with the known phenotypic consequences of proprotein convertase subtilisin/kexin type 1 (PCSK1) gene mutations. Based on the molecular diagnosis, alternate medical and dietary management was implemented for diabetes insipidus, polyphagia, and micropenis. CONCLUSIONS: Whole-exome sequencing provides a powerful diagnostic tool to clinicians managing rare genetic disorders with multiple perplexing clinical manifestations.
Authors: Galen Cortina; Chandra N Smart; Douglas G Farmer; Sunita Bhuta; William R Treem; Ivor D Hill; Martín G Martín Journal: Hum Pathol Date: 2007-01-29 Impact factor: 3.466
Authors: S O'Rahilly; H Gray; P J Humphreys; A Krook; K S Polonsky; A White; S Gibson; K Taylor; C Carr Journal: N Engl J Med Date: 1995-11-23 Impact factor: 91.245
Authors: Jiafang Wang; Galen Cortina; S Vincent Wu; Robert Tran; Jang-Hyeon Cho; Ming-Jer Tsai; Travis J Bailey; Milan Jamrich; Marvin E Ament; William R Treem; Ivor D Hill; Jorge H Vargas; George Gershman; Douglas G Farmer; Laurie Reyen; Martín G Martín Journal: N Engl J Med Date: 2006-07-20 Impact factor: 91.245
Authors: Michael Benzinou; John W M Creemers; Helene Choquet; Stephane Lobbens; Christian Dina; Emmanuelle Durand; Audrey Guerardel; Philippe Boutin; Beatrice Jouret; Barbara Heude; Beverley Balkau; Jean Tichet; Michel Marre; Natascha Potoczna; Fritz Horber; Catherine Le Stunff; Sebastien Czernichow; Annelli Sandbaek; Torsten Lauritzen; Knut Borch-Johnsen; Gitte Andersen; Wieland Kiess; Antje Körner; Peter Kovacs; Peter Jacobson; Lena M S Carlsson; Andrew J Walley; Torben Jørgensen; Torben Hansen; Oluf Pedersen; David Meyre; Philippe Froguel Journal: Nat Genet Date: 2008-07-06 Impact factor: 38.330
Authors: I Sadaf Farooqi; Karolien Volders; Richard Stanhope; Robert Heuschkel; Anne White; Emma Lank; Julia Keogh; Stephen O'Rahilly; John W M Creemers Journal: J Clin Endocrinol Metab Date: 2007-06-26 Impact factor: 5.958
Authors: Michael Yourshaw; S Paige Taylor; Aliz R Rao; Martín G Martín; Stanley F Nelson Journal: Brief Bioinform Date: 2014-03-12 Impact factor: 11.622
Authors: Q Gu; M Yazdanpanah; M van Hoek; A Hofman; X Gao; F W M de Rooij; E J G Sijbrands Journal: J Hum Hypertens Date: 2014-07-17 Impact factor: 3.012
Authors: Yogikala Prabhu; Elias H Blanco; Ming Liu; Juan R Peinado; Matthew C Wheeler; Nicholas Gekakis; Peter Arvan; Iris Lindberg Journal: Endocrinology Date: 2014-05-14 Impact factor: 4.736
Authors: Michael Wilschanski; Montaser Abbasi; Elias Blanco; Iris Lindberg; Michael Yourshaw; David Zangen; Itai Berger; Eyal Shteyer; Orit Pappo; Benjamin Bar-Oz; Martin G Martín; Orly Elpeleg Journal: PLoS One Date: 2014-10-01 Impact factor: 3.240
Authors: Hadley Stevens Smith; J Michael Swint; Seema R Lalani; Jose-Miguel Yamal; Marcia C de Oliveira Otto; Stephan Castellanos; Amy Taylor; Brendan H Lee; Heidi V Russell Journal: Genet Med Date: 2018-05-14 Impact factor: 8.822